The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 401–500 of 1,007
Ghobadi, H., Ahari, S. S., Kameli, A., & lari, S. (2012) · PubMed Central · Cited by 104
The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD
Ramachandran, K., McCusker, C., Connors, M., ZuWallack, R., & Lahiri, B. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972308096711 · Cited by 91
Suzuki, M., Muro, S., Ando, Y., Omori, T., Shiota, T., Endo, K., Satô, S., Aihara, K., Matsumoto, M., Suzuki, S., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1233 · Cited by 98
Organ Allocation in Lung Transplant
Davis, S. Q., & Garrity, E. R. (2007) · CHEST Journal · doi:10.1378/chest.07-0011 · Cited by 105
Update in Chronic Obstructive Pulmonary Disease 2006
Rabe, K. F., Beghé, B., Luppi, F., & Fabbri, L. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-586up · Cited by 98
BOURDIN, A. A., Burgel, P., Chanez, P., Garcia, G., Perez, T., & Roche, N. (2009) · European Respiratory Review · doi:10.1183/09059180.00005509 · Cited by 111
Ferrari, R., Tanni, S. É., Caram, L., Corrêa, C., Corrêa, C. R., & Godoy, I. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-24 · Cited by 109
“[19].”
Chronic obstructive pulmonary disease subpopulations and phenotyping
Segal, L. N., & Martínez, F. J. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.035 · Cited by 99
“[52] [53] [54] As depicted in Fig 1, much less is known about the value of multiple other variables combined from different dimensions for what future investigations are needed to achieve a more holistic view of subjects with COPD to understand relevant subtypes amenable for different therapeutic approaches.”
Tai Chi for chronic obstructive pulmonary disease (COPD)
Ngai, S. P., Jones, A. Y., & Tam, W. W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009953.pub2 · Cited by 95
Ancochea, J., Badiola, C., Duran‐Tauleria, E., Rio, F. G., Miravitlles, M., Muñoz, L., Sobradillo, V., & Soriano, J. B. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2008.06.001 · Cited by 97
Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype
Celli, B. R., Locantore, N., Tal‐Singer, R., Riley, J., Miller, B. E., Vestbo, J., Yates, J., Silverman, E. K., Owen, C. A., Divo, M. J., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02146-2017 · Cited by 96
Self-citationSoriano, J. B., & Rodriguez‐Roisin, R. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201102-017rm · Cited by 108
Aerobic Exercise Training in Very Severe Chronic Obstructive Pulmonary Disease
Paneroni, M., Simonelli, C., Vitacca, M., & Ambrosino, N. (2017) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000667 · Cited by 96
“This level was proposed as it represents the lowest level of the body mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E)] score.(6) Studies in patients with CRF, defined as the presence of arterial oxygen tension less than 55 mm Hg and home treatment with oxygen for at lea…”
BackgroundAbdulai, R. M., Jensen, T. J., Patel, N. R., Polkey, M. I., Jansson, P., Celli, B. R., & Rennard, S. I. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0615ci · Cited by 91
Self-citationBaseline 6-Min Walk Distance Predicts Survival in Lung Transplant Candidates
Martinu, T., Babyak, M. A., O’Connell, C. F., Carney, R. M., Trulock, E. P., Davis, R. D., Blumenthal, J. A., & Palmer, S. M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02264.x · Cited by 90
“Age, years, median (interquartile range) 53 (43, 59) Female, n (%) 212 (56) Caucasian, n (%) 331 (88) Native disease, N (%) COPD 153 (41) Alpha-1 Antitrypsin deficiency 25 (7) CF 51 (14) 1ILD 84 (22) Sarcoidosis 16 (4) PPH 24 (6) Eisenmenger’s syndrome 7 (2) 2Miscellaneous diseases 16 (4) Transplanted during study, N…”
BackgroundClinical Significance of Radiologic Characterizations in COPD
Han, M. K., Bartholmai, B. J., Liu, L. X., Murray, S., Curtis, J. L., Sciurba, F. C., Kazerooni, E. A., Thompson, B., Frederick, M., Li, D., et al. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903341513 · Cited by 95
“Because BODE score accurately predicts mortality in COPD (12) and the strong correlation between emphysema and BODE that we report, future research is needed to clarify whether radiographic emphysema quantification versus BODE score is the better predictor of mortality.”
BackgroundMethodJohannessen, A., Nilsen, R. M., Storebø, M. L., Gulsvik, A., Eagan, T., & Bakke, P. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2276oc · Cited by 94
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
Korn, S., Kerwin, E., Naycı, S. A., Amos, C., Owen, R. J., & Lassen, C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.008 · Cited by 94
Nambu, A., Zach, J. A., Schroeder, J., Jin, G. Y., Kim, S. S., Kim, Y., Schnell, C., Bowler, R. P., & Lynch, D. A. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.09.010 · Cited by 98
“The BODE index was calculated as previously reported [24].”
MethodHacker, S., Lambers, C., Höetzenecker, K., Pollreisz, A., Aigner, C., Lichtenauer, M., Mangold, A., Niederpold, T., Zimmermann, M., Taghavi, S., et al. (2009) · Clinical Laboratory · Cited by 112
State of the art: How to set up a pulmonary rehabilitation program
JENKINS, S. C., Hill, K., & Cecins, N. M. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01849.x · Cited by 106
Vaes, A. W., Wouters, E. F. �., Franssen, F. M. E., Uszko‐Lencer, N. H. M. K., Stakenborg, K. H. P., Westra, M., Meijer, K., Schols, A. M. W. J., Janssen, P. P., & Spruit, M. A. (2011) · CHEST Journal · doi:10.1378/chest.10-3005 · Cited by 94
Almagro, P., Salvadó, M., Garcia-Vidal, C., Rodríguez-Carballeira, M., Cuchi, E., Torres, J., & Ll Heredia, J. (2012) · Respiration · doi:10.1159/000331224 · Cited by 94
Oelsner, E. C., Hoffman, E. A., Folsom, A. R., Carr, J. J., Enright, P., Kawut, S. M., Kronmal, R. A., Lederer, D. J., Lima, J. A. C., Lovasi, G. S., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2570 · Cited by 99
Shin, S., King, C. S., Brown, A. W., Albano, M. C., Atkins, M. B., Sheridan, M. J., Ahmad, S., Newton, K., Weir, N. A., Shlobin, O. A., et al. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.08.009 · Cited by 94
“breathlessness as measured by the modified Medical Research Council dyspnea scale and functional status on six-minute walk test), is the most commonly used prognostic tool [23].”
MethodDetermining prognosis in acute exacerbation of COPD
Flattet, Y., Garin, N., Serratrice, J., Perrier, A., Stirnemann, J., & Carballo, S. (2017) · International Journal of COPD · doi:10.2147/copd.s122382 · Cited by 94
“Although albumin values may be of interest as a marker for patients’ nutrition state, we found no association with the clinical outcomes.(28,32) However, patients’ weight analyzed through multiple imputation appears to play a protective role in the risk of death or readmissions during the exacerbation of COPD.”
Boland, J. W., Martin, J., Wells, A. U., & Ross, J. R. (2013) · Palliative Medicine · doi:10.1177/0269216313493467 · Cited by 93
Chronic Obstructive Pulmonary Disease: CT Quantification of Airways Disease
Hackx, M., Bankier, A. A., & Gevenois, P. A. (2012) · Radiology · doi:10.1148/radiol.12111270 · Cited by 105
Rabinovich, R. A., & Vilaró, J. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328336438d · Cited by 92
COMET: a multicomponent home-based disease-management programmeversusroutine care in severe COPD
Kessler, R., Casán, P., Koehler, D., Tognella, S., Viejo, J. L., Negro, R. W. D., Lobato, S. D., Reissig, K., González-Moro, J. M. R., Devouassoux, G., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01612-2017 · Cited by 94
Wilt, T. J., Niewoehner, D. E., Kim, C.-B., Kane, R. L., Linabery, A. M., Tacklind, J., MacDonald, R. H., & Rutks, I. R. (2005) · PsycEXTRA Dataset · doi:10.1037/e439492005-001 · Cited by 108
“0 percent).(79) This study was relatively small, suffered from poor physician and patient compliance, and did not obtain spirometry directly in the primary care setting.”
BackgroundMethodInfluentialNutritional Aspects of Chronic Obstructive Pulmonary Disease
King, D. A., Cordova, F., & Scharf, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-092et · Cited by 92
“Indeed, BMI is a component in the calculation of the BODE index (11), a prognostic indicator of mortality.”
BackgroundOprescu, N., McCormack, F. X., Byrnes, S., & Kinder, B. (2012) · Lung · doi:10.1007/s00408-012-9419-3 · Cited by 92
“, COPD/emphysema, BODE index) [26].”
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort
Drummond, M., Kirk, G. D., Astemborski, J. A., Marshall, M. M., Mehta, S. H., McDyer, J. F., Brown, R. H., Wise, R. A., & Merlo, C. A. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200702 · Cited by 92
Eberhardt, R., Gompelmann, D., Schuhmann, M., Reinhardt, H., Ernst, A., Heußel, C. P., & Herth, F. J. F. (2012) · CHEST Journal · doi:10.1378/chest.11-2886 · Cited by 92
Voll‐Aanerud, M., Eagan, T., Wentzel‐Larsen, T., Gulsvik, A., & Bakke, P. S. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.012 · Cited by 106
Six-min walk test in a healthy adult Arab population
Alameri, H. F., Al-Majed, S. A., & Al-Howaikan, A. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.012 · Cited by 107
Prediction of the rate of decline in FEV1 in smokers using quantitative computed tomography
Yuan, R., Hogg, J. C., Pare, P. D., Sin, D. D., Wong, J. C., Nakano, Y., McWilliams, A. M., Lam, S., & Coxson, H. O. (2009) · Thorax · doi:10.1136/thx.2008.112433 · Cited by 72
Methodology for Using Long-Term Accelerometry Monitoring to Describe Daily Activity Patterns in COPD
Hecht, A., Ma, S., Porszasz, J., Casaburi, R., & Netw, F. T. C. C. R. (2009) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902755044 · Cited by 91
“However, it may be wondered whether correlations between exercise tolerance and survival seen in COPD patients (4, 5, 7, 11, 13, 17) represent causeand-effect or whether identification of those with higher exercise tolerance simply identifies a subgroup with higher activity level.”
BackgroundHeart Rate Variability and Disease Characteristics in Patients with COPD
Camillo, C. A., Pitta, F. D. O., Possani, H. V., Barbosa, M. V. R. A., Marques, D. S. D. O., Cavalheri, V., Probst, V. S., & Brunetto, A. F. (2008) · Lung · doi:10.1007/s00408-008-9105-7 · Cited by 100
“The severity of the disease may be assessed using different outcomes such as the forced expiratory volume in one second (FEV1) [3, 4] and the BODE index [5].”
BackgroundMicroalbuminuria and Hypoxemia in Patients with Chronic Obstructive Pulmonary Disease
Casanova, C., de-Torres, J. P., Navarro‐González, J. F., Aguirre‐Jaime, A., Toledo, P., Córdoba-Lanús, E., Baz, R., & Celli, B. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0360oc · Cited by 102
Self-citationSmargiassi, A., Inchingolo, R., Tagliaboschi, L., Berardino, A. D. M., Valente, S., & Corbo, G. M. (2014) · Respiration · doi:10.1159/000358564 · Cited by 96
Benzo, R. P., Chang, C. H., Farrell, M. H., Kaplan, R. M., Ries, A. L., Martínez, F. J., Wise, R. A., Make, B. J., & Sciurba, F. C. (2010) · Respiration · doi:10.1159/000296504 · Cited by 91
Briggs, A. H. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.37 · Cited by 90
“The efficacy and safety of fluticasone propionate (250 microg)/ salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.”
MethodInfluentialChronic Obstructive Pulmonary Disease in Elderly Patients
Cortopassi, F. F., Gurung, P., & Pinto-Plata, V. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.06.006 · Cited by 90
Self-citationComparison of daily physical activity between COPD patients from Central Europe and South America
Pitta, F. D. O., Breyer, M., Hernandes, N. A., Teixeira, D. D. C., Sant'Anna, T. J. P., Fontana, A. D., Probst, V. S., Brunetto, A. F., Spruit, M. A., Wouters, E. F. �., et al. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.019 · Cited by 109
“Results concerning BMI, FEV1, MMRC and 6MWT were used to calculate the BODE index as described by Celli et al.(24)”
MethodMiravitlles, M., Soler‐Cataluña, J. J., Rubio, M. C., Molina, J., Almagro, P., Quintano, J. A., Trigueros, J. A., Piñera, P., Simón, A., Riesco, J. A., et al. (2013) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2013.00016 · Cited by 88
“Multidimensional indices such as the BODE index (body mass index, airflow obstruction, dyspnoea, and exercise capacity) have demonstrated excellent prognostic value.(26,27) If the 6-minute walking test is not performed routinely, its substitution by the frequency of exacerbations (BODEx index) provides similar prognos…”
BackgroundMiravitlles, M., Ferrer, M., Pont, À., Viejo, J. L., Masa, J. F., Gabriel, R., Jimenez-Ruiz, C. A., Villasante, C., Fernández-Fau, L., & Sobradillo, V. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.01.012 · Cited by 88
Advanced Chronic Obstructive Pulmonary Disease: Innovative Approaches to Palliation
Rocker, G. M., Sinuff, T., Horton, R., & Hernandez, P. (2007) · Journal of Palliative Medicine · doi:10.1089/jpm.2007.9951 · Cited by 95
“41 However, even patients with the highest BODE index quartile scores had a 30%–40% 2-year mortality.”
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD
Al-shair, K., Dockry, R., Mallia-Milanes, B., Kolsum, U., Singh, D., & Vestbo, J. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.021 · Cited by 88
“BODE index is a multidimensional tool assessing uniquely the multisystem effects of COPD.(16) The association of low mood with BODE may reflect the overall effects of the many aspects of COPD and underlines the multisystem nature of COPD and the limitations of relying on FEV1 only when grading COPD.”
MethodInfluentialSarcopenia Associated with Chronic Obstructive Pulmonary Disease
Kim, S. H., Shin, M., Shin, Y. B., & Kim, K. U. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.2.65 · Cited by 97
Spruit, M. A., Pennings, H.-J., Janssen, P. P., Does, J. D., Scroyen, S., Akkermans, M. A., Mostert, R., & Wouters, E. F. M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.003 · Cited by 89
Effects of Unsupported Upper Extremity Exercise Training in Patients With COPD
Costi, S., Crisafulli, E., Antoni, F. D., Beneventi, C., Fabbri, L. M., & Clini, E. M. (2009) · CHEST Journal · doi:10.1378/chest.09-0165 · Cited by 100
Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD
Vagaggini, B., Costa, F., Antonelli, S., Simone, C. D., Cusatis, G. D., Martino, F., Santerini, S., & Paggiaro, P. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.01.023 · Cited by 93
Airway Count and Emphysema Assessed by Chest CT Imaging Predicts Clinical Outcome in Smokers
Díaz, A. A., Valim, C., Yamashiro, T., Estépar, R. S. J., Ross, J. C., Matsuoka, S., Bartholmai, B. J., Hatabu, H., Silverman, E. K., & Washko, G. R. (2010) · CHEST Journal · doi:10.1378/chest.10-0542 · Cited by 88
Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD
Luo, Y., Zhou, L., Li, Y., Guo, S., Li, X., Zheng, J., Zhu, Z., Chen, Y., Huang, Y., Chen, R., et al. (2016) · Respiratory Care · doi:10.4187/respcare.04358 · Cited by 97
Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances
Carolan, B. J., & Sutherland, E. R. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.010 · Cited by 96
Hartman, J. E., Boezen, H. M., de Greef, M. H., & ten Hacken, N. H. T. (2013) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2013.06.029 · Cited by 97
de Oliveira, H. G., Cruz, F. F., Antunes, M. A., Neto, A. V. M., de Oliveira, G. A., Svartman, F. M., Borgonovo, T., Rebelatto, C. L. K., Weiss, D. J., Brofman, P. R. S., et al. (2016) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0315 · Cited by 88
Divisi, D., Francesco, C. D., Leonardo, G. D., & Crisci, R. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs257 · Cited by 97
“[12] was 4.”
Salzman, S. H. (2009) · CHEST Journal · doi:10.1378/chest.07-1682 · Cited by 97
Budweiser, S., Hitzl, A. P., Jörres, R. A., Schmidbauer, K., Heinemann, F., & Pfeifer, M. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-92 · Cited by 85
“Accordingly, body mass index (BMI) and six-minute walk distance (6-MWD) have been revealed as prognostic markers [5].”
BackgroundBurney, P., & Hooper, R. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys011 · Cited by 92
Chen, C., Shi, L., Li, Y., Wang, X., & Yang, S. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9322-4 · Cited by 89
“The existing score index, such as the BODE index (Celli et al. 2004), has been used to monitor and provide good predictive information in a clinical practice, while they are graded with only partial variables that are not adequate for highthroughput analysis.”
MethodOutpatient vs. home-based pulmonary rehabilitation in COPD: a randomized controlled trial
Mendes de Oliveira, J. C., Studart Leit�o Filho, F. S., Malosa Sampaio, L. M., Negrinho de Oliveira, A. C., Hirata, R., Costa, D., Donner, C. F., & de Oliveira, L. V. (2010) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-5-6-401 · Cited by 81
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy
Valipour, A., Herth, F. J. F., Burghuber, O. C., Criner, G. J., Vergnon, J., Goldin, J. G., Sciurba, F. C., & Ernst, A. (2013) · European Respiratory Journal · doi:10.1183/09031936.00133012 · Cited by 85
“This is of particular importance, as the daily physical activity of patients with COPD is mainly associated with dynamic hyperinflation, regardless of severity classification [29].”
BackgroundMethodInfluentialDivo, M. J., Cabrera, C., Casanova, C., Marín, J. M., Pinto-Plata, V., de-Torres, J. P., Zulueta, J. J., Zagaceta, J., Sánchez-Salcedo, P., Bertó, J., et al. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.1.2.2014.0117 · Cited by 103
Self-citationEnergy expenditure during daily activities as measured by two motion sensors in patients with COPD
Cavalheri, V., Donária, L., Ferreira, T., Finatti, M. E., Camillo, C. A., Ramos, E. M. C., & Pitta, F. D. O. (2011) · European Respiratory Journal · doi:10.1016/j.rmed.2011.01.004 · Cited by 85
Sava, F., Laviolette, L., Bernard, S., Breton, M.-J., Bourbeau, J., & Maltais, F. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-55 · Cited by 84
“Obese and overweight patients had higher FEV1 and FEV1/FVC ratio than their lean counterparts, an observation that was previously reported [3,4,34,35].”
BackgroundResultCicoira, M., Maggioni, A. P., Latini, R., Barlera, S., Carretta, E., Jánosi, A., Soler‐Soler, J., Anand, I. S., Cohn, J. N., & Val-HeFT Investigators (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.10.016 · Cited by 88
“A protective effect of higher BMI has also been reported in different settings, such as ischaemic heart disease [18,19], advanced age [20], and chronic obstructive pulmonary disease [21].”
BackgroundWelte, T., & Groneberg, D. A. (2006) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2006.02.004 · Cited by 84
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Papaioannou, A. Ι., Bartziokas, Κ., Tsikrika, S., Karakontaki, F., Kastanakis, E., BANYA, W. A. S., Haniotou, A., Papiris, S. A., Loukides, S., Polychronopoulos, V. S., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00013112 · Cited by 94
“Although the BODE index is the most studied multidimensional score assessing COPD severity, in our study we decided to use the ADO and DOSE indexes, in order to avoid bias from patients with impaired mobility which would not be eligible to perform a six-minute walking test, that is essential for the evaluation of BODE…”
MethodDevelopment and Validation of a Survey-Based COPD Severity Score
Eisner, M. D., Trupin, L. S., Katz, P., Yelin, E. H., Earnest, G. E., Balmes, J. R., & Blanc, P. D. (2005) · CHEST Journal · doi:10.1378/chest.127.6.1890 · Cited by 84
Should we treat obesity in COPD? The effects of diet and resistance exercise training
McDonald, V. M., Gibson, P. G., Scott, H. A., Baines, P. J., Hensley, M., Pretto, J. J., & Wood, L. G. (2016) · Respirology · doi:10.1111/resp.12746 · Cited by 86
Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD
Waatevik, M. J., Johannessen, A., Real, F. G., Aanerud, M., Hardie, J. A., Bakke, P. S., & Eagan, T. (2016) · European Respiratory Journal · doi:10.1183/13993003.00975-2015 · Cited by 86
Furutate, R., Ishii, T., Motegi, T., Hattori, K., Kusunoki, Y., Gemma, A., & Kida, K. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5772 · Cited by 93
Protein Biomarkers for COPD Outcomes
Serban, K. A., Pratte, K., & Bowler, R. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.004 · Cited by 90
Wada, H., Ikeda, A., Maruyama, K., Yamagishi, K., Barnes, P. J., Tanigawa, T., Tamakoshi, A., & Iso, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79860-4 · Cited by 92
Association Between Periodontitis and Chronic Obstructive Pulmonary Disease in a Chinese Population
Si, Y., Fan, H. X., Song, Y., Zhou, X., Zhang, J., & Wang, Z. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.110472 · Cited by 85
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease
Tantucci, C., Donati, P., Nicosia, F., Bertella, E., Redolfi, S., De Vecchi, M., Corda, L., Grassi, V., & Zulli, R. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.11.004 · Cited by 59
Cleutjens, F. A. H. M., Janssen, D. J. A., Ponds, R., Dijkstra, J. B., & Wouters, E. F. �. (2014) · BioMed Research International · doi:10.1155/2014/697825 · Cited by 93
“However, cognitive functioning is not a part of the current prognostic indices, such as the BODE index [77].”
BackgroundHill, K., Dolmage, T. E., Woon, L. J., Coutts, D., Goldstein, R. S., & Brooks, D. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02089.x · Cited by 93
Eaton, T., Young, P., Nicol, K., & Kolbe, J. (2006) · Chronic Respiratory Disease · doi:10.1191/1479972306cd077oa · Cited by 85
Hill, N. S. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200511-121jh · Cited by 114
Telephone-based coping skills training for patients awaiting lung transplantation
Blumenthal, J. A., Babyak, M. A., Carney, R. M., Keefe, F. J., Davis, R. D., LaCaille, R. A., Parekh, P. I., Freedland, K. E., Trulock, E., & Palmer, S. M. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.3.535 · Cited by 82
Pessoa, B. V., Arcuri, J. F., Labadessa, I. G., Costa, J. N. F., Sentanin, A. C., & Lorenzo, V. A. P. D. (2014) · Brazilian Journal of Physical Therapy · doi:10.1590/bjpt-rbf.2014.0041 · Cited by 108
Mjid, M., Cherif, J. K., Toujani, S., Ouahchi, Y., Hmida, A. B., & Béji, M. (2015) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.165289 · Cited by 83
FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease
Bhatt, S. P., Nakhmani, A., Fortis, S., Strand, M. J., Silverman, E. K., Sciurba, F. C., & Bodduluri, S. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202303-0450oc · Cited by 95
Königshoff, M., Kneidinger, N., & Eickelberg, O. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12528 · Cited by 102
Chang, C. L., Sullivan, G., Karalus, N., Mills, G., McLachlan, J. D., & Hancox, R. J. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01866.x · Cited by 83
Chronic Obstructive Pulmonary Disease in the elderly
Incalzi, R. A., Scarlata, S., Pennazza, G., Santonico, M., & Pedone, C. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.10.001 · Cited by 83
“In a population of COPD patients with a mean age N 65 years, mortality was best predicted by a composite index (the BODE index) including FEV1 along with nutritional status, exercise capacity, and dyspnea [55].”
MethodFat‐free mass index predicts survival in patients with idiopathic pulmonary fibrosis
Nishiyama, O., Yamazaki, R., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., & Tohda, Y. (2016) · Respirology · doi:10.1111/resp.12941 · Cited by 86
Foreman, M. G., Wilson, C. G., DeMeo, D. L., Hersh, C. P., Beaty, T. H., Cho, M. H., Ziniti, J. P., Curran‐Everett, D., Criner, G. J., Hokanson, J. E., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201611-838oc · Cited by 86
Upala, S., Panichsillapakit, T., Wijarnpreecha, K., Jaruvongvanich, V., & Sanguankeo, A. (2016) · Transplant International · doi:10.1111/tri.12721 · Cited by 81
Bak, S. H., Kwon, S. O., Han, S., & Kim, W. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1191-y · Cited by 88
Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review
Jo, Y. S. (2022) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2022.0074 · Cited by 81
Mahmood, K., Wahidi, M. M., Thomas, S. M., Argento, A. C., Ninan, N. A., Smathers, E. C., & Shofer, S. L. (2015) · Respiration · doi:10.1159/000381103 · Cited by 81
O’Callaghan, A., Laking, G. R., Frey, R. A., Robinson, J., & Gott, M. (2014) · Palliative Medicine · doi:10.1177/0269216314536089 · Cited by 81
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus
the COPDGene and ECLIPSE Investigators, Hersh, C. P., Make, B. J., Lynch, D. A., Barr, R. G., Bowler, R. P., Calverley, P. M. A., Castaldi, P. J., Cho, M. H., Coxson, H. O., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-164 · Cited by 87
“*BODE = Body mass, airflow Obstruction, Dyspnea, Exercise capacity [38].”
BackgroundMoving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
Vanfleteren, L. E. G. W., Kocks, J. W. H., Stone, I. S., Breyer‐Kohansal, R., Greulich, T., Lacedonia, D., Buhl, R., Fabbri, L. M., Pavord, I. D., Barnes, N. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203602 · Cited by 80
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.